Latest News
People who have experienced symptoms for months or longer after being infected exhibit different immune and hormonal responses to the virus, a new study finds.
- September 19, 2023Source: Yale Daily News
The Yale School of Medicine’s new Center for Infection & Immunity, which launched on Aug. 18, is researching post-acute infection syndromes while encouraging diversity, elevating scientists and incorporating patients as research partners.
- September 11, 2023
The effects of infection don't necessarily end when the first symptoms subside. The new center will work to unravel the mysteries of lingering diseases.
- September 08, 2023Source: Yale Daily News
Yale researchers, led by Professor Mark Saltzman, have successfully created an mRNA no-shot COVID vaccine, which successfully protects against COVID-19 in mice.
- August 30, 2023
Using microparticles instead of injection as a delivery system, Yale scientists have developed an inhalable vaccine that protects against the SARS-CoV-2 virus. The technique also has the potential to deliver gene replacement therapy and other treatments to the lungs.
- August 28, 2023
Cancer vaccines utilizing mRNA vaccine technology have such potential that ARPA-H, a newly established White House-originated program, has made it the focus of its first ever grant to be split among teams at Emory University, Yale School of Medicine, and the University of Georgia.
- August 09, 2023Source: YaleNews
The new model will help scientists find human-specific mechanisms for regulating cholesterol levels and potentially for treating chronic liver diseases.
- July 27, 2023
A new study led by Yale Cancer Center researchers at Yale School of Medicine reveals that a specific population of CD8+ T-cells marked by IL-7R play an important role in better understanding anti-tumor memory.
- July 25, 2023Source: Stamford Advocate
A group of Yale researchers is working on a new kind of vaccine they believe could change the world: instead of acting against a pathogen, the vaccine would reduce the risk of transmission for mosquito-and-tick-borne illnesses by targeting the insects themselves.
- July 12, 2023Source: YaleNews
When activated, a protein found in cells that line the body’s tissues can inhibit viral spread — offering the potential for a new defense against COVID-19.